SCHEMBL4551365

SCHEMBL4551365

CC(C)(C)CC(C)(C)Nc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.48
NPSR1 Q6W5P4 2/20 0.41
HTT P42858 3/20 0.40
LMNA P02545 2/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 2/20 0.39
IDO1 P14902 1/20 0.38
MAPT P10636 5/20 0.38
HPGD P15428 2/20 0.38
GAA P10253 1/20 0.38
RAB9A P51151 1/20 0.38
ALDH1A1 P00352 5/20 0.36
TDP1 Q9NUW8 3/20 0.36
HSD17B10 Q99714 2/20 0.36
EGFR P00533 1/20 0.36
CTSD P07339 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALOX12 P18054 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11726250 0.92 ALDH1A1 (0.50) POLBNPSR1HTTLMNACYP2D6
SCHEMBL19880106 0.88 POLB (0.39) POLBNPSR1HTTLMNAIDO1
SCHEMBL11749783 0.86 MAPT (0.44) POLBNPSR1HTTLMNACYP2D6
SCHEMBL29911655 0.79 POLB (0.46) POLBNPSR1HTTLMNACYP2D6
SCHEMBL583081 0.79 CCNE2 (0.44) NPSR1LMNACYP2D6TSHRMAPT
SCHEMBL3076978 0.79 TAAR1 (0.48) NPSR1LMNACYP2D6TSHRIDO1
SCHEMBL23456183 0.78 MAPT (0.43) POLBHTTLMNAMAPTHPGD
SCHEMBL12177981 0.78 POLB (0.38) POLBNPSR1HTTLMNACYP2D6
SCHEMBL11691246 0.77 NPSR1 (0.41) NPSR1LMNACYP2D6TSHRIDO1
SCHEMBL1162021 0.77 NPSR1 (0.62) POLBNPSR1LMNACYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023112038-A1 NEUTROPHIL EXOCYTOSIS INHIBITORS IMMUNYX PHARMA LTD. (IL) 2023-06-22 WO disclosed
CN-111556864-B Compounds with stabilizing effect, preparation method and use thereof, compositions containing same and method for stabilizing organic components 弗劳恩霍弗应用研究促进协会 2022-07-08 CN disclosed
CN-114606012-A Polymerizable liquid crystal material and polymerized liquid crystal film 默克专利股份有限公司 2022-06-10 CN disclosed
EP-3218350-B1 PROCESS FOR FORMING AMINE BY DIRECT AMINATION REACTION RHODIA OPERATIONS (FR) 2022-01-05 EP disclosed
CN-113677781-A Metalworking fluids containing branched alcohol propoxylates 巴斯夫欧洲公司 2021-11-19 CN disclosed
CN-111032826-A Polymerizable LC medium and polymer film with flat light dispersion 默克专利股份有限公司 2020-04-17 CN disclosed
CN-106456581-A Trka kinase inhibitors, compositions and methods thereof 默沙东公司 2017-02-22 CN disclosed
US-7504510-B2 Graftable hindered amine light stabilizers CIBA SPECIALTY CHEMICALS CORP. (US) 2009-03-17 US disclosed
US-20060173107-A1 Graftable hindered amine light stabilizers CIBA SPECIALTY CHEMICALS CORP. 2006-08-03 US disclosed
EP-0327318-B1 Heat-sensitive recording materials FUJI PHOTO FILM CO LTD (JP) 1995-07-19 EP disclosed
EP-0327318-A2 Heat-sensitive recording materials FUJI PHOTO FILM CO., LTD. (JP) 1989-08-09 EP disclosed
EP-0288240-A2 Heat-sensitive diazo recording material FUJI PHOTO FILM CO., LTD. (JP) 1988-10-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173107-A1 Graftable hindered amine light stabilizers IDO1, MAOA, TPH1 POLB 1026/4885NPSR1 714/4885HTT 600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.